|
US4927828A
(en)
*
|
1985-03-08 |
1990-05-22 |
The Trustees Of Princeton University |
Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
|
|
US4684653A
(en)
*
|
1985-03-08 |
1987-08-04 |
The Trustees Of Princeton University |
Pyrido(2,3-d)pyrimidine derivatives
|
|
US5026851A
(en)
*
|
1985-03-08 |
1991-06-25 |
The Trustees Of Princeton University |
Pyrido[2,3-]pyrimidine derivatives
|
|
GB8513754D0
(en)
*
|
1985-05-31 |
1985-07-03 |
Jones T R |
Anti-cancer quinazoline derivatives
|
|
US5187167A
(en)
*
|
1986-03-27 |
1993-02-16 |
Imperial Chemical Industries Plc |
Pharmaceutical compositions comprising quinazolin-4-one derivatives
|
|
GB8607683D0
(en)
*
|
1986-03-27 |
1986-04-30 |
Ici Plc |
Anti-tumor agents
|
|
US4833145A
(en)
*
|
1986-06-30 |
1989-05-23 |
The Trustees Of Princeton University |
4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives
|
|
US4818819A
(en)
*
|
1986-10-20 |
1989-04-04 |
The Trustees Of Princeton University |
Process for the preparation of fused pyridine compounds
|
|
US4902796A
(en)
*
|
1986-10-20 |
1990-02-20 |
The Trustees Of Princeton University |
6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
|
|
GB8707053D0
(en)
*
|
1987-03-25 |
1987-04-29 |
Ici Plc |
Anti-tumour agents
|
|
US4857530A
(en)
*
|
1987-11-03 |
1989-08-15 |
Warner-Lambert Company |
Substituted quinazolinones as anticancer agents
|
|
GB8727737D0
(en)
*
|
1987-11-26 |
1987-12-31 |
Ici Plc |
Antitumour agents
|
|
JP2830008B2
(ja)
*
|
1988-04-01 |
1998-12-02 |
武田薬品工業株式会社 |
縮合ピリミジン誘導体
|
|
US5223620A
(en)
*
|
1988-04-01 |
1993-06-29 |
Takeda Chemical Industries, Ltd. |
Pyrido[2,3-d]pyrimidine compounds useful as intermediates
|
|
GB8809978D0
(en)
*
|
1988-04-27 |
1988-06-02 |
Ici Plc |
Anti-tumour agents
|
|
EP0365763A1
(en)
*
|
1988-09-30 |
1990-05-02 |
Agouron Pharmaceuticals, Inc. |
Antiproliferative cyclic compounds
|
|
GB8829296D0
(en)
*
|
1988-12-15 |
1989-01-25 |
Ici Plc |
Anti-tumour compounds
|
|
US5252573A
(en)
*
|
1988-12-15 |
1993-10-12 |
Imperial Chemical Industries Plc |
Anti-tumor agents
|
|
US4996206A
(en)
*
|
1989-12-11 |
1991-02-26 |
The Trustees Of Princeton University |
N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
|
|
US5160727A
(en)
*
|
1990-02-13 |
1992-11-03 |
Warner-Lambert Company |
Tumor cell sensitization method using quinazolinedione derivatives
|
|
US5286726A
(en)
*
|
1990-04-12 |
1994-02-15 |
The Regents Of The University Of Michigan |
Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
|
|
ZA913730B
(en)
*
|
1990-05-30 |
1992-02-26 |
Ici Plc |
Anti-tumor compounds
|
|
US6762188B1
(en)
|
1990-06-19 |
2004-07-13 |
Smithkline Beecham Corporation |
Pharmaceutically active benzoquinazoline compounds
|
|
GB9013615D0
(en)
*
|
1990-06-19 |
1990-08-08 |
Wellcome Found |
Pharmaceutical compounds
|
|
GB9105771D0
(en)
*
|
1991-03-19 |
1991-05-01 |
Cancer Res Inst Royal |
Anti-cancer compounds
|
|
US5145854A
(en)
*
|
1991-11-27 |
1992-09-08 |
Nair Madhavan G |
1-formyl-5,8,10-trideazafolates
|
|
GB9205320D0
(en)
*
|
1992-03-11 |
1992-04-22 |
Ici Plc |
Anti-tumour compounds
|
|
GB9205907D0
(en)
*
|
1992-03-18 |
1992-04-29 |
Cancer Res Inst Royal |
Anti-cancer compounds
|
|
US5430148A
(en)
*
|
1992-03-31 |
1995-07-04 |
Agouron Pharmaceuticals, Inc. |
Antiproliferative quinazolines
|
|
CH684644A5
(de)
*
|
1992-07-13 |
1994-11-15 |
Eprova Ag |
5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
|
|
GB9223352D0
(en)
*
|
1992-11-06 |
1992-12-23 |
Ici Plc |
Tricyclic compounds
|
|
US5821231A
(en)
*
|
1993-12-06 |
1998-10-13 |
Cytel Corporation |
CS-1 peptidomimetics, compositions and methods of using same
|
|
CA2177840A1
(en)
*
|
1993-12-06 |
1995-06-15 |
Thomas S. Arrhenius |
Cs-1 peptidomimetics, compositions and methods of using the same
|
|
WO1995015973A1
(en)
*
|
1993-12-06 |
1995-06-15 |
Cytel Corporation |
Cs-1 peptidomimetics, compositions and methods of using the same
|
|
US5770573A
(en)
*
|
1993-12-06 |
1998-06-23 |
Cytel Corporation |
CS-1 peptidomimetics, compositions and methods of using the same
|
|
US5804396A
(en)
*
|
1994-10-12 |
1998-09-08 |
Sugen, Inc. |
Assay for agents active in proliferative disorders
|
|
US5837815A
(en)
*
|
1994-12-15 |
1998-11-17 |
Sugen, Inc. |
PYK2 related polypeptide products
|
|
US5837524A
(en)
*
|
1994-12-15 |
1998-11-17 |
Sugen, Inc. |
PYK2 related polynucleotide products
|
|
US5593999A
(en)
*
|
1995-06-07 |
1997-01-14 |
Nair; Madhavan G. |
Non-classical folate analogue inhibitors of glycinamide ribonucleotide formyltransferase (GARFT)
|
|
AU5984296A
(en)
*
|
1995-06-07 |
1996-12-30 |
Sugen, Inc. |
Quinazolines and pharmaceutical compositions
|
|
US6716575B2
(en)
|
1995-12-18 |
2004-04-06 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
|
US7119174B2
(en)
*
|
1995-12-18 |
2006-10-10 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
|
AU5596998A
(en)
*
|
1996-12-11 |
1998-07-03 |
New York University Medical Center |
Pyk2 related products and methods
|
|
US6818440B2
(en)
*
|
1997-04-28 |
2004-11-16 |
Sugen, Inc. |
Diagnosis and treatment of alk-7 related disorders
|
|
US6228641B1
(en)
|
1997-05-20 |
2001-05-08 |
Sugen, Inc. |
Diagnosis and treatment of PTP04 related disorders
|
|
US7115710B2
(en)
*
|
1997-06-11 |
2006-10-03 |
Sugen, Inc. |
Diagnosis and treatment of PTP related disorders
|
|
US6342593B1
(en)
|
1997-06-11 |
2002-01-29 |
Sugen, Inc. |
Diagnosis and treatment of ALP related disorders
|
|
US6388063B1
(en)
*
|
1997-06-18 |
2002-05-14 |
Sugen, Inc. |
Diagnosis and treatment of SAD related disorders
|
|
EP1049786A2
(en)
|
1998-01-21 |
2000-11-08 |
Sugen, Inc. |
Human orthologues of wart
|
|
JP2002522009A
(ja)
|
1998-04-14 |
2002-07-23 |
スージェン・インコーポレーテッド |
Ｓｔｅ−２０関連蛋白質キナーゼ
|
|
US6861442B1
(en)
*
|
1998-12-30 |
2005-03-01 |
Sugen, Inc. |
PYK2 and inflammation
|
|
GB9904275D0
(en)
|
1999-02-24 |
1999-04-21 |
Cancer Res Campaign Tech |
Anti-cancer compounds
|
|
US6521607B1
(en)
|
1999-09-23 |
2003-02-18 |
Pharmacia Corporation |
(R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
|
|
US6476057B1
(en)
|
1999-09-23 |
2002-11-05 |
G.D. Searle & Co. |
Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
|
|
US6677382B1
(en)
|
1999-09-23 |
2004-01-13 |
Pharmacia Corporation |
Substituted N,N-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
|
|
US6835546B1
(en)
|
1999-10-22 |
2004-12-28 |
Pharmacia & Upjohn Company |
Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
|
|
US7364866B2
(en)
*
|
1999-10-22 |
2008-04-29 |
Pharmacia & Upjohn Company |
Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
|
|
US20030162223A1
(en)
*
|
1999-10-22 |
2003-08-28 |
Lowery David E. |
Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
|
|
US20030082534A1
(en)
*
|
1999-11-16 |
2003-05-01 |
Peter Lind |
Novel G protein-coupled receptors
|
|
CA2388865A1
(en)
*
|
1999-11-16 |
2001-05-25 |
Pharmacia & Upjohn Company |
Novel g protein-coupled receptors
|
|
US6143776A
(en)
*
|
2000-02-02 |
2000-11-07 |
Sunesis Pharmaceuticals, Inc. |
Tosylproline analogs as thymidylate synthase inhibitors
|
|
US20030003451A1
(en)
*
|
2000-02-23 |
2003-01-02 |
Gabriel Vogeli |
Novel G protein-coupled receptors
|
|
US20030027308A1
(en)
*
|
2000-05-30 |
2003-02-06 |
Sugen Incorporated |
Novel human protein phosphatases identified from genomic sequencing
|
|
CA2321345A1
(fr)
*
|
2000-10-02 |
2002-04-02 |
Abdelbast Guerfi |
Utilisation du graphite dans un composite pour reduire l'accumulation de glace
|
|
US20040157306A1
(en)
*
|
2000-11-13 |
2004-08-12 |
Sugen Incorporated |
Mammalian protein phosphatases
|
|
US20050069976A1
(en)
*
|
2001-02-14 |
2005-03-31 |
Peter Lind |
Protein-coupled receptor
|
|
DE60237902D1
(de)
|
2001-08-31 |
2010-11-18 |
Btg Int Ltd |
ANTIKREBS-CYCLOPENTAiG CHINAZOLINE-DERIVATE
|
|
ATE526028T1
(de)
|
2001-08-31 |
2011-10-15 |
Btg Int Ltd |
Verwendung von cyclopentaägüchinazoline-derivaten zur krebsbehandlung
|
|
WO2003042390A1
(en)
*
|
2001-11-13 |
2003-05-22 |
Sugen, Inc. |
Mammalian protein phosphatases
|
|
US7537774B2
(en)
*
|
2005-12-23 |
2009-05-26 |
Orion Therapeautics, Llc |
Therapeutic formulation
|
|
US20110008347A1
(en)
*
|
2006-12-01 |
2011-01-13 |
Agency For Science ,Technology And Research |
Cancer-related protein kinases
|
|
DK2150514T3
(en)
|
2007-04-11 |
2019-02-18 |
Merck & Cie |
18F-LABELED FOLATES
|
|
US8273617B2
(en)
|
2009-09-30 |
2012-09-25 |
Suvolta, Inc. |
Electronic devices and systems, and methods for making and using the same
|